Sponsored by
GE Healthcare, one of the largest MRI manufacturers in the US, is partnering with Imaging Biometrics (IB) to distribute advanced imaging software that can help doctors better distinguish brain tumor progression from treatment effects with "Fractional Tumor Burden" maps. This is encouraging news for the brain cancer community. We hope to see more widespread adoption of these tools that make it easier to monitor brain tumors and understand how they are responding to treatments. For a great webinar on Fractional Tumor Burden maps, click here.